Phesgo, manufactured by Roche, contains a combination of Pertuzumab and Trastuzumab and is used in the treatment of specific types of breast cancer.
CS Duale demanded the swift removal of all substandard, falsified, poor-quality, counterfeit, and unregistered medicines from the Kenyan market.